HomeCompareAUD vs MRK

AUD vs MRK: Dividend Comparison 2026

AUD yields 5299.15% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AUD wins by $744.19M in total portfolio value
10 years
AUD
AUD
● Live price
5299.15%
Share price
$0.09
Annual div
$4.96
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$744.25M
Annual income
$19,077,020.21
Full AUD calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — AUD vs MRK

📍 AUD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAUDMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AUD + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AUD pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AUD
Annual income on $10K today (after 15% tax)
$450,427.35/yr
After 10yr DRIP, annual income (after tax)
$16,215,467.18/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, AUD beats the other by $16,206,870.47/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AUD + MRK for your $10,000?

AUD: 50%MRK: 50%
100% MRK50/50100% AUD
Portfolio after 10yr
$372.15M
Annual income
$9,543,567.00/yr
Blended yield
2.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

AUD
Analyst Ratings
1
Buy
1
Hold
1
Sell
Consensus: Buy
Price Target
$2.00
+2036.8% upside vs current
Range: $2.00 — $2.00
Altman Z
-2.7
Piotroski
4/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AUD buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAUDMRK
Forward yield5299.15%2.81%
Annual dividend / share$4.96$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$744.25M$57.7K
Annual income after 10y$19,077,020.21$10,113.78
Total dividends collected$569.36M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$2.00$128.54

Year-by-year: AUD vs MRK ($10,000, DRIP)

YearAUD PortfolioAUD Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$275,657$264,957.26$11,213$373.04+$264.4KAUD
2$3,707,916$3,412,962.38$12,667$512.06+$3.70MAUD
3$25,419,981$21,452,510.94$14,439$708.14+$25.41MAUD
4$95,923,585$68,724,205.59$16,640$988.16+$95.91MAUD
5$223,822,475$121,184,238.97$19,432$1,394.07+$223.80MAUD
6$371,622,854$132,132,806.30$23,057$1,992.90+$371.60MAUD
7$500,153,388$102,516,933.44$27,889$2,894.79+$500.13MAUD
8$599,637,831$64,473,705.83$34,518$4,286.29+$599.60MAUD
9$677,733,055$36,120,576.20$43,912$6,494.35+$677.69MAUD
10$744,251,389$19,077,020.21$57,714$10,113.78+$744.19MAUD

AUD vs MRK: Complete Analysis 2026

AUDStock

Audacy, Inc., a multi-platform audio content and entertainment company, engages in the radio broadcasting business in the United States. The company owns and operates radio stations in various formats, such as news, sports, talk, classic rock, urban, adult contemporary, alternative, country, and others, as well as offers integrated marketing solutions across its broadcast, digital, podcast, and event platforms. It also creates live and original events, including concerts and live performances, and crafted food and beverage events. The company was formerly known as Entercom Communications Corp. and changed its name to Audacy, Inc. in April 2021. Audacy, Inc. was founded in 1968 and is headquartered in Philadelphia, Pennsylvania.

Full AUD Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this AUD vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AUD vs SCHDAUD vs JEPIAUD vs OAUD vs KOAUD vs MAINAUD vs JNJAUD vs ABBVAUD vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.